Table 1.
Clinical and demographic features of the described SLE patients with COVID-19 during pregnancy and their offspring.
| Case 1 | Case 2 | |
|---|---|---|
| Maternal age (years) | 31 | 39 |
| Disease duration (years) | 16 | 20 |
| Disease characteristics (SLICC/ACR score)Damage Index, organ involvement | 1 (arthritis) | 2 (arthritis, renal) |
| SLEDAI score, (description) | 2 (low complement) | 4 (arthritis) |
| Medication use | Azathioprine | Azathioprine |
| Hydroxychloroquine | Etanercept | |
| Prednisone | ||
| Gravidity, parity (n) | G1P0 | G2P1 |
| Mode of delivery | Induced labor | Caesarean section |
| Sex of the newborn | Female | Male |
| Gestational age (weeks, days) | 38, 1 | 38, 5 |
| Birthweight (grams) | 2880 | 4205 |
| APGAR score (after 5 minutes) | 9 | 9 |
| Congenital malformations | – | – |
SLICC/ACR damage index indicates Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index, SLEDAI indicates Systemic Lupus Erythematosus Disease Activity Index score.